BRIEF published on 08/13/2024 at 07:05, 1 year 3 months ago Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates Financial Results Cash Position Revenue Guidance Valneva Vaccine Development
BRIEF published on 08/13/2024 at 07:05, 1 year 3 months ago Valneva publie ses résultats financiers du premier semestre 2024 et fournit des mises à jour sur l'entreprise Résultats Financiers Valneva Prévisions De Revenus Développement De Vaccins Situation De Trésorerie
PRESS RELEASE published on 08/13/2024 at 07:00, 1 year 3 months ago Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates Valneva reports first-half 2024 financial results as total revenues reach €70.8 million with net profit of €34.0 million. Company confirms full-year guidance and updates strategic pipeline expansion Revenues Financial Results Net Profit Valneva Strategic Pipeline
PRESS RELEASE published on 08/13/2024 at 07:00, 1 year 3 months ago Valneva publie ses résultats financiers du premier semestre 2024 et fait un point sur ses activités
BRIEF published on 08/06/2024 at 08:35, 1 year 3 months ago Valneva Announces Share and Voting Right Changes as of July 31, 2024 Euronext Paris Voting Rights Shares Biopharmaceutical Valneva
BRIEF published on 08/06/2024 at 08:35, 1 year 3 months ago Valneva annonce des modifications au titre du capital et des droits de vote au 31 juillet 2024 Euronext Paris Actions Biopharmaceutique Droit De Vote Valneva
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 3 months ago VALNEVA - Declaration of shares and voting rights: July 31, 2024 VALNEVA declared changes in shares and voting rights including sale, transfer, and granting of double voting rights on various dates Voting Rights Shares Sale Transfer Valneva
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 3 months ago VALNEVA - Déclaration d’actions et de droits de vote : 31 juillet 2024 Déclaration d'actions et de droits de vote de Valneva pour le 31 juillet 2024. Cession et passages de titres avec droits de vote double Cession Droits De Vote Actions Valneva Double
BRIEF published on 07/17/2024 at 22:05, 1 year 4 months ago Essai de Phase 3 VALOR : Valneva et Pfizer finalisent la vaccination primaire contre la maladie de Lyme Essai Clinique Valneva Pfizer VLA15 Lyme
BRIEF published on 07/17/2024 at 22:05, 1 year 4 months ago VALOR Phase 3 Trial: Valneva and Pfizer Finalize Primary Lyme Disease Vaccination Clinical Test Valneva Pfizer VLA15 Lyme
Published on 12/05/2025 at 02:35, 10 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 26 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 26 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 20 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 25 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 26 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 41 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 4 hours 41 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 4 hours 43 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 19 hours 11 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 19 hours 26 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
